CNTA — Centessa Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Centessa Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	7.23	595	394	257	482
Net Total Receivables	2.93	16.8	26.7	39.1	45.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11.2	629	438	315	536
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.162	1.17	13	11.8
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11.7	630	444	360	577
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.62	24.6	38.3	39.4	58
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	8.62	138	108	124	175
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	3.1	492	336	236	402
Total Liabilities & Shareholders' Equity	11.7	630	444	360	577
Total Common Shares Outstanding